High Tower Advisors, LLC Rigel Pharmaceuticals Inc Transaction History

High Tower Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$1.12 - $1.57 $9,935 - $13,927	8,871 New	8,871 $13,000
Q3 2023 Nov 08, 2023	BUY	$1.07 - $1.39 $10,864 - $14,114	10,154 New	10,154 $10,000
Q1 2023 May 11, 2023	BUY	$1.25 - $2.0 $21,442 - $34,308	17,154 New	17,154 $22,000
Q3 2020 Nov 13, 2020	SELL	$1.78 - $4.13 $18,707 - $43,406	-10,510 Closed	0 $0
Q1 2020 May 21, 2020	BUY	$1.27 - $3.0 $127 - $300	100 Added 0.96%	10,510 $17,000
Q4 2019 Feb 14, 2020	SELL	$1.6 - $2.43 $88 - $133	-55 Reduced 0.53%	10,410 $22,000
Q2 2019 Aug 13, 2019	SELL	$2.02 - $2.61 $808 - $1,044	-400 Reduced 3.68%	10,465 $27,000
Q4 2018 Feb 14, 2019	BUY	$2.08 - $3.36 $1,799 - $2,906	865 Added 8.65%	10,865 $25,000
Q1 2018 May 15, 2018	SELL	$3.54 - $4.54 $354 - $454	-100 Reduced 0.99%	10,000 $35,000
Q4 2017 Feb 14, 2018	BUY	$3.23 - $4.3 $323 - $430	100 Added 1.0%	10,100 $39,000
Q2 2017 Aug 14, 2017	BUY	N/A	10,000	10,000 $27,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.